Arkolith/Insider Trading/UNCY/Form 4

Aggarwal Gaurav

DirectorUnicycive Therapeutics, Inc. (UNCY) · full profile →Form 4 · filed Oct 10, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 9, 2024Conversion(C)5.5M——10.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 9, 2024Disposed to issuer(D)3K$1000.00$2.7M4K

Transaction Codes

C
Conversion of a derivative
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-086928) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML